| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Impaired inhibitory Fcgamma receptor IIB expression on B cells in chronic inflammatory demyelinating polyneuropathy. | Proc Natl Acad Sci U S A | 2009 | 1.35 |
| 2 | Central role of JC virus-specific CD4+ lymphocytes in progressive multi-focal leucoencephalopathy-immune reconstitution inflammatory syndrome. | Brain | 2011 | 1.22 |
| 3 | Sustained efficacy of natalizumab in the treatment of relapsing-remitting multiple sclerosis independent of disease activity and disability at baseline: real-life data from a Swiss cohort. | Clin Neuropharmacol | 2012 | 1.01 |
| 4 | Melanoma occurring during treatment with fingolimod for multiple sclerosis: a case report. | Arch Dermatol | 2011 | 0.77 |
| 5 | The thermolabile variant of 5,10-methylenetetrahydrofolate reductase is a possible risk factor for amyotrophic lateral sclerosis. | Amyotroph Lateral Scler | 2010 | 0.76 |